Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) — The “Intravenous (IV) Hydration Therapy Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F” report has been added to ResearchAndMarkets.com’s offering.
The expanding global Intravenous (IV) Hydration Therapy market, currently valued at USD 3.04 billion, is forecast to experience a surge in demand, anticipating reaching USD 4.49 billion by 2028. This significant growth trajectory is underpinned by a Compound Annual Growth Rate (CAGR) of 6.76%.
Key Market Drivers
- Surge in Surgical Procedures: The market is fueled by an increase in surgical interventions necessitating IV hydration therapy for patient support pre-, intra-, and post-operation. Optimal hydration is essential for successful surgical outcomes and swift patient recovery.
- Wellness and Performance Optimization: The wellness trend contributes to market expansion, with IV hydration therapy sought for performance enhancement and lifestyle support. This efficient hydration method has attracted athletes and active individuals, bolstering market growth.
- Aging Population Requirements: A growing elderly demographic reliant on IV hydration therapy for managing age-related health issues has propelled market advancement. The therapy plays a vital role in preventing dehydration-related health complications among older adults.
Key Market Challenges
- Regulatory and Legal Frameworks: Healthcare providers must comply with stringent regulations, quality standards, and training requirements, impacting the market’s operation.
- Public Perception and Education: Discerning the therapeutic necessity versus lifestyle use of IV hydration therapy is influenced by public awareness and scientific evidence.
- Expertise in Medical Profession: Highly skilled practitioners are essential for safe and effective IV therapy delivery, influencing service quality and availability.
- Rise in Wellness Oriented Use
- Customizable Treatment Options
Energy-boosting treatments take the lead in market services, while medicated components dominate the composition landscape. Hospitals and clinics are the primary end-users of IV hydration therapy.
The Asia Pacific region holds a dominant market position, closely followed by North America, with its advanced healthcare systems and health-conscious populations fueling IV therapy demand.
Key Market Players
Notable organizations are defining the competitive landscape, each playing a substantial role in aligning with market dynamics and consumer needs.
A selection of companies mentioned in this report includes:
- Core IV Therapy, LLC
- Cryojuvenate UK Ltd.
- B. Braun Medical Inc.
- Otsuka Pharmaceutical Co. Ltd.
- NexGen Health Inc.
- JW Life Science Corporation
- Amanta Healthcare Ltd.
- Baxter International Inc.
- Drip Hydration Inc.
|No. of Pages
|Estimated Market Value (USD) in 2023
|Forecasted Market Value (USD) by 2028
|Compound Annual Growth Rate
For more information about this report visit https://www.researchandmarkets.com/r/7uorz6
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Intravenous (IV) Hydration Therapy Market